HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 16 May 2017

April’s CEAs.....

Our quick search for CEA’s published in April uncovered 43 articles.   In the right-hand column of this blog is a CEA Archive, which includes our CEA search results by month.  Below are those in our areas of interest.
  • Goto D, Shih YT, Lecomte P, Olson M, Udeze C, Park Y, et al. Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis. PharmacoEconomics. 2017.
  • Othus M, Bansal A, Koepl L, Wagner S, Ramsey S. Accounting for Cured Patients in Cost-Effectiveness Analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2017;20(4):705-9.
  • Wikman-Jorgensen PE, Llenas-Garcia J, Perez-Porcuna TM, Hobbins M, Ehmer J, Mussa MA, et al. Microscopic observation drug-susceptibility assay vs. Xpert(R) MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis. Tropical medicine & international health : TM & IH. 2017.